MabThera (Rituximab) in Combination With CHOP (or CHOP-like) Chemotherapy in Patients With Aggressive B-Cell Lymphoma

Clinical trial NCT02486952 · COMPLETED

Trial details

NCT number: NCT02486952
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Study type: OBSERVATIONAL

Lymphoma, Lymphoma, Large B-Cell, Diffuse, Non-Hodgkin's Lymphoma, Lymphoma, Non Hodgkin, Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Start date: 2005-08-01
Primary completion: 2011-01-01
Enrollment: 154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.